Thrombosis
From the Journals
Five risk factors may predict thrombus on LAA occlusion implants
With a new clinical risk score, patients deemed at high risk showed a twofold increased rate of this worrisome complication.
From the Journals
DOACs linked to lower mortality than vitamin K antagonist: 3-year TAVR registry
Mortality and bleeding advantage favors DOACs over VKA in TAVR patients who are candidates for anticoagulation.
Feature
Early heparin treatment linked to lower COVID-19 mortality
Latest News
FDA okays 1-month dual antiplatelet therapy for Abbott’s Xience stents
The new labeling, similarly granted in Europe for as little as 28 days, gives the Xience stents the shortest DAPT indication in the world, Abbott...
From the Journals
Prophylactic anticoagulation tied to lower death rate in COVID
Prophylactic use of low-dose anticoagulation to prevent venous thromboembolism was associated with reduced 60-day mortality in patients...
From the Journals
Reversal agents curb DOAC-related bleeding but deaths still high
The meta-analysis of more than 4,000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.
From the Journals
Are left atrial thrombi that defy preprocedure anticoagulation predictable?
Features that predispose to such persistent LA thrombi, which are not very rare, could potentially guide more targeted TEE screening before rhythm...
From the Journals
First risk score to predict bleeding risk after TAVR
PREDICT-TAVR was developed and validated in two national registries in Europe and outperformed existing risk scores developed outside TAVR.
From the Journals
Evidence builds for iPhone 12 interference with cardiac devices
Greater public awareness is needed, as are further studies to confirm the results, including differences in susceptibility among devices, the...
Conference Coverage
Single subcutaneous shot offers fast, potent platelet inhibition in STEMI
The effect was seen within 15 minutes of receiving RUC-4, an investigational glycoprotein IIb/IIIa inhibitor, with no thrombocytopenia, in a phase...
Guidelines
New AHA/ASA guideline on secondary stroke prevention
Identifying the cause of a first stroke or transient ischemic attack is key to developing strategies to prevent repeat events, the AHA/ASA says in...